Changes in [3H]zolpidem and [3H]Ro 15-1788 binding in rat globus pallidus and substantia nigra pars reticulata following a nigrostriatal tract lesion

Brain Research

Volumn 862, Issue 1-2, 2000, Pages 280-283

  Chadha, Anita ^a   Howell, Owain ^b   Atack, John R ^b   Sur, Cyrille ^b   Duty, Susan ^a  

^a Hodgkin B   (United Kingdom)

^b NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

Autoradiography; GABA(A); Rat; Ro 15 1788; Zolpidem

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; FLUMAZENIL; FLUNITRAZEPAM; RECEPTOR SUBUNIT; ZOLPIDEM; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; DIAGNOSTIC AGENT; PYRIDINE DERIVATIVE; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AUTORADIOGRAPHY; BINDING AFFINITY; BRAIN INJURY; CONTROLLED STUDY; DRUG RECEPTOR BINDING; GLOBUS PALLIDUS; MALE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SHORT SURVEY; SUBSTANTIA NIGRA; ANIMAL; ARTICLE; CHEMISTRY; METABOLISM; NERVE DEGENERATION; PATHOLOGY; PHYSIOLOGY; RADIOASSAY; SPRAGUE DAWLEY RAT;

ANIMALS; AUTORADIOGRAPHY; FLUMAZENIL; GABA AGONISTS; GABA MODULATORS; GLOBUS PALLIDUS; MALE; NERVE DEGENERATION; PYRIDINES; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; SUBSTANTIA NIGRA; TRITIUM;

EID: 0034678144     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02081-3     Document Type: Article

References (15)

1. 4-subunit: Prevalence, distribution, pharmacology and subunit architecture in situ. J. Neurochem. 69:1997;806-814.
2. A receptor subunit changes induced by unilateral 6-OHDA lesion of the nigrostriatal pathway. Mol. Brain Res. 48:1997;243-250.
3. A receptor subunit gene expression in the rodent basal ganglia and thalamus. Neuroscience. 95:2000;119-126.
4. Chesselet M.F., Delfs J.M. Basal ganglia and movement disorders: an update. Trends Neurosci. 13:1996;277-280.
5. A receptor heterogeneity in the adult rat brain; differential regional and cellular distribution of seven major subunits. J. Comp. Neurol. 359:1995;154-194.
6. Gerfen C.G., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma F.J., Sibley D.R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 250:1990;1429-1432.
7. Hefti F., Melamed E., Sahakian B.J., Wurtman R.J. Circling behaviour in rats with partial unilateral nigrostriatal lesions: effects of amphetamine, apomorphine and DOPA. Pharmacol. Biochem. Behav. 12:1980;185-188.
8. Marsden C.D. Parkinson's disease. J. Neurol. Neurosurg. Psych. 57:1994;672-681.
9. 2 subunit mRNAs following ischemic cortical lesions in rats. Brain Res. 816:1999;234-237.
10. 3H] flunitrazepam binding sites. J. Neurochem. 49:1987;890-899.
11. Pan H.S., Penney J.B., Young A.B. γ-Aminobutyric acid and benzodiazepine receptor changes induced by unilateral 6-hydroxydopamine lesions of the medial forebrain bundle. J. Neurochem. 45:1985;1396-1404.
12. Paxinos G., Watson C. The rat brain. Stereotaxic Co-ordinates. 2nd Edition :1986;Academic, San Diego, CA.
13. A receptor subtypes. Pharmacol. Rev. 47:1995;181-234.
14. A receptors in rat brain. Brain Res. 822:1999;265-270.
15. A receptor subunit mRNAs in the rat brain I. Telencephalon, diencephalon, mesencephalon. J. Neurosci. 12:1992;1040-1062.